Cognitive and nootropic products are one of the fastest-growing private-label categories, and one of the most tightly watched. The formulas are not especially difficult — the hard part is the wording, because cognition sits closer to the medical line than almost any other claim area. This guide covers how a nootropic product is actually built, and where brands usually get held up.

Single active or a stack?

The first decision is positioning, and it drives everything downstream:

  • Single-active products — one clearly named molecule or extract on the label. Easiest to explain, easiest to price, easiest to defend at customs and in claim review. The usual choices are Alpha GPC, citicoline or a standardised botanical.
  • Stacks — a blend of actives, usually two to six. Higher perceived value and a better story, but harder to standardise, and every added ingredient adds a claim-review question.
  • Calm-focus products — a different proposition again, usually built around L-theanine and botanical nervines rather than stimulant-style actives. Often positioned as caffeine-adjacent rather than as a cognitive enhancer.

In practice, the brands that scale fastest launch one hero single-active product first, then add a stack once the first listing has data behind it.

Actives and how they behave in production

  • Alpha GPC — a choline donor and one of the most requested nootropic actives. It is hygroscopic, so it picks up moisture from the air; that makes moisture control in blending and packaging a real formulation constraint, not a detail.
  • Citicoline — a stable, well-documented alternative choline source with fewer handling problems than Alpha GPC. Often the easier first launch for exactly that reason.
  • Standardised botanicals — ginkgo, bacopa, lion's mane and rhodiola. Standardisation matters more than the headline number: a 20:1 extract claim means very little unless the marker compound is specified.
  • L-theanine and GABA — common in calm-focus formulas. These two are a good example of why formulation and regulatory review have to happen together: the same molecule can sit on different sides of the line depending on the market and the route of administration.
  • B vitamins and magnesium — frequently included for their role in normal energy metabolism and normal nervous-system function. These support conventional, well-established wording rather than new claim territory.

Choose the dosage form before the formula

  • Hard capsules — the default for nootropics. Highest active load per unit, best moisture protection, lowest cost per dose, and what serious buyers expect.
  • Gummies — excellent for consumer appeal and repeat purchase, but with a real ceiling on how much botanical or hygroscopic active they can carry, and they need a moisture-tight pack.
  • Powders and stick packs — the right home for multi-actives stacks, and the easiest format to differentiate by flavour.
  • Liquid drops — good for a premium single active, but require a preserved, stability-tested formula and a proper stability study at the pack.

Stability and moisture are the usual failure point

Nootropic formulas fail stability more often than they fail potency. If the active is hygroscopic, or the botanical is sensitive to oxygen or light, then the pack is part of the formulation: an induction-sealed bottle with a desiccant sachet, a moisture-barrier laminate or an opaque container can be the difference between a product that holds specification for two years and one that does not. Test the finished product in the container you plan to sell, not in a generic jar.

Where cognitive claims stop

  • Describe the product in terms of normal structure or function — the wording most markets allow for a supplement — rather than in terms of a named condition.
  • Avoid disease-adjacent language such as memory-loss, dementia or attention-disorder terms. Those move the product into medicine territory in essentially every market.
  • Be careful with implied cognition claims on the pack itself. Keep the label to the product name, specification and count, and place any claim wording in the market-specific artwork where a regulatory advisor can sign it off.
  • Do not lift a competitor's claim panel. What passes for one seller in one market may be rejected for you, and the wording around cognition is where that difference is most likely to bite.

MOQ, sampling and lead times

A practical starting point with a manufacturer that supports small batches is MOQ 500 units per SKU, samples in 3–5 days, production shipped within 7 days, and a certificate of analysis with every batch.

How Haiyue Shengda works

We develop and fill capsules, softgels, gummies, tablets, liquid drops, powders, teas and personal-care formats in our own 5,000+ m² factory with 7 production lines and 34 machines, under FDA facility registration and HACCP, cGMP and ISO 22000. Custom formulations and outer-packaging design are free, with the first design sketch in about two hours. Browse our capsules and softgels range, read the FAQ, or contact us — we reply within one hour on working days.